Molecular serological characteristics of weak D antigen types of the Rhesus system

Abstract

Aim. To estimate the spread of weak D antigen types of the Rhesus system in the citizens of the Russian Federation and a possibility of serologically identifying these types. Subjects and methods. The red blood cells and DNA of people with weakened expression of D antigen were investigated using erythrocyte agglutination reaction in salt medium (2 methods); agglutination reaction in the gel columns containing IgM + IgG anti-D antibodies, indirect antiglobulin test with IgG anti-D antibodies (2 methods); polymerase chain reaction to establish the type of weak D. Results. A rhesus phenotype was determined in 5100 people in 2014-2015. The weakened agglutinable properties of red blood cells were detected in 102 (2%) examinees. 63 examinees underwent genotyping to identify the variants of the weak D antigen, which identified 6 weak D types. There were the most common weak D types 3 (n=31 (49.2%)) and weak D type 1 (n=18 (28.6%)), including weak D type 1.1 in one (1.6%) case. The other 4 weak D antigen types were as follows: weak D type 2 (14.3% (n=9)), weak D type 15 (4.8% (n=3)), weak D type 4.2 (DAR) (1.6% (n=1)) and weak D type 6 (1.6% (n=1)). The antiglobulin test in the gel column containing antiglobulin serum was the most sensitive serological assay to identify the weak D antigen. Only a molecular test could establish weak D type 15 in 2 samples of red blood cells with Ccdee and ccdEe phenotypes. Conclusion. The weak D antigen could be serologically identified in 96.8% of cases. When testing for weak D, particular attention should be given to people with the D-negative phenotype who had the C or E antigens. Our investigations conducted for the first time in Russia will be able to improve the immunological safety of red blood cell-containing medium transfusions for patients.

References

  1. Cherif-Zahar B, Mattei MG, Le van Kim C, Bailly P, Carton JP, Collin Y. Localization of the human Rh blood group gene structure to chromosome region 1p34.3-1p36.1 by in situ hybridization. Human Genet. 1991;6:398-400. doi: 10.1007/BF00201843
  2. Okuda H, Suganuma H, Kamesaki T, Kumada M, Tsudo N, Omi T, Iwamoto S, Kajii E. The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE through complete sequencing. Biochem Biophys Res Communicat. 2000;274:670-683. doi: 10.1006/bbrc.2000.3206
  3. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood. 2000;95:3662-3668. doi: 10.1016/S0887-7963(01)80058-4
  4. Scott M. Rh serology - Coordinators report. Transfusion Clin. Biol. 1996; 3: 333-337. doi: 10.1016/s1246-7820(96)80040-1
  5. Scott M., Section L.A. Rh serology. Coordinators report. Transfusion Clinique Biologique. 2002;9:23-29. doi: 10.1016/s1246-7820(01)00211-7
  6. Liu W, Avent ND, Jones JW, Scott ML, Voak D. Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemia cells. Blood. 1999;94(12):3986-3996.
  7. Daniels G. Variants of RhD - current testing and clinical consequences. Br J Haematol. 2013;161:461-470. doi: 10.1111/bjh.12275
  8. Shao CP, Maas JH, Su YQ, Kohler M, Legler TJ. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang. 2002;83(2):156-161. doi: 10.1046/j.1423-0410.2002.00192.x
  9. Stratton F. A new Rh allelomorph. Nature. 1946;158:25-26. doi: 10.1038/158025c0
  10. Agre PC, Davies DM, Issitt PD, Lamy BM, Schmidt PJ, Treacy M, Vengelen-Tyler V. A proposal to standardize terminology for weak D antigen. Transfusion. 1992;32:86-87. doi: 10.1046/j.1537-2995.1992.32192116441.x
  11. Rhesus base website, http://www.uni-ulm.de/fwagner/RH/RB.
  12. Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood. 1999;93:385-393.
  13. Avent ND, Madgett TE, Lee ZE, Head DJ, Maddocks DG, Skinner LH. Molecular biology of Rh protein and relevance to molecular medicine. Expert Rev Mol Med. 2006; 8:1-20. doi: 10.1017/S1462399406010969
  14. Conroy MJ, Bullough PA, Merrick M, Avent ND. Modeling the human rhesus proteins: implications for structure and function. Br J Hematol. 2005;131:543-551. doi: 10.1111/j.1365-2141.2005.05786.x
  15. Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apheresis Scie. 2011;44:81-91. doi: 10.1016/j.transci.2010.12.013
  16. Wagner FF, Frohmajer A, Ladewig B, Eicher NI, Lonicer CB, Muller TH, Siegel MH, Flegel WA. Weak D alleles express distinct phenotypes. Blood. 2000;95:2699-2708. doi: 10.1016/S0887-7963(01)80057-2
  17. Dogic V, Bingulac-Popovic J, Babic I, Hundric-Haspl Z, Jurakovic-Loncar N, Mratinovic-Mikulandra J, Vuk T, Balija M, Jukic I. Distribution of weak D types in Croatian population. Transfus Med. 2011;21:278-279. doi: 10.1111/j.1365-3148.2011.01071.x
  18. Rodrigues MJ, Rodrigues F, Tilley L, Poole I, Chabert T, Sousa G. Several new examples of weak D type 38 in the Portuguese population. Transfusion. 2006;46(suppl.):141A-142A (abstract). doi: 10.1111/j.1537-995.2006.01023_1.x
  19. St-Louis M, Richard M, Cote M, Ethier C, Long A. Weak D type 42 cases found in individuals of European descent. Immunohematology. 2011;27:20-24.
  20. Sandler SG, Flegel WA, Westhoff CM, Denomme GA, Delaney M, Keller MA, Jonson ST, Katz L, Queenan JT, Vassallo RR, Simon CD. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. Transfusion. 2015;55:680-689. doi: 10.1111/trf.12941
  21. Levitt J, ed. Standards for blood banks and transfusion service. 29th ed. Bethesda (MD): American Association of Blood Banks; 2014.
  22. Головкина Л.Л., Стремоухова А.Г., Пушкина Т.Д., Оловникова Н.И. Случай выявления антигена системы Резус D weak 15-го типа. Гематология и трансфузиология. 2014;59(4):23-24.
  23. Пискунова Т.М. Изучение некоторых изоантигенов крови человека и создание кадров доноров и резерва замороженной крови редких групп: Автореф. дис. ... канд. мед. наук. М.; 1970.
  24. Пискунова Т.М. Редкий фактор крови Du. Проблемы гематологии. 1973;5:3-9.
  25. Оловникова Н.И., Митерев Г.Ю. Современная стратегия определения резус-принадлежности крови: проблема Du фенотипа в трансфузиологической и акушерской практике. Справочник заведующего КДЛ. 2010;4:5-16.
  26. Haspel RL, Westhoff CM. How do I manage Rh typing in obstetric patients? Transfusion. 2015;55:470-474. doi: 10.1111/trf.12995

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies